|Bid||2.0900 x 28000|
|Ask||2.1000 x 4000|
|Day's range||2.1150 - 2.2400|
|52-week range||0.4600 - 3.6800|
|Beta (5Y monthly)||2.60|
|PE ratio (TTM)||N/A|
|Earnings date||10 Mar 2021 - 15 Mar 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||5.25|
Trevena (TRVN) will provide updates on its newly launched drug and other pipeline products when it releases its third-quarter 2020 results.
Is (TRVN) Outperforming Other Medical Stocks This Year?
As of late, it has definitely been a great time to be an investor in Trevena.